Skip to content
September 4, 2026 The daily briefing for counsel & executives — Subscribe free
Get the Digest
Litigation & Disputes

Hernia Mesh Lawsuit: $88 Million Verdict, Bard Payouts, and Who Can Still File in 2026

The hernia mesh lawsuit landscape shifted again on August 4, 2026, when a federal jury awarded $88 million to a Massachusetts plaintiff in the first Covidien bellwether trial — the largest compensatory verdict in the mesh litigation’s 15-year history. Meanwhile, Bard’s parent company has already resolved roughly 38,000 claims for more than $1 billion, and Atrium and Ethicon cases are largely winding down. Where a claim stands now depends almost entirely on which manufacturer made the mesh.

These lawsuits generally allege that specific mesh products caused chronic pain, infection, adhesions, bowel obstruction, organ damage, hernia recurrence, or the need for revision surgery. The manufacturers named have denied wrongdoing or disputed that their products caused the injuries described.

Hernia Mesh Lawsuit Quick Facts

ItemCurrent information
Main defendantsC.R. Bard/Davol, Covidien/Medtronic, Atrium Medical, Ethicon/Johnson & Johnson
Central allegationsDefective design, inadequate warnings, manufacturing defects, failure to disclose risks
Bard federal caseIn re Davol, Inc./C.R. Bard, Inc. Polypropylene Hernia Mesh Products Liability Litigation, MDL No. 2846
Covidien federal caseIn re Covidien Hernia Mesh Products Liability Litigation (No. II), MDL No. 3029
Atrium federal caseIn re Atrium Medical Corp. C-Qur Mesh Products Liability Litigation, MDL No. 2753
Bard settlementOver $1 billion, ~38,000 claims, payments confidential and still processing
Covidien bellwether verdict$88 million (Patterson v. Covidien, Aug. 4, 2026)
Public claims formNone open — no nationwide online form exists
Lawsuit typeIndividual product-liability suits coordinated through MDLs, not one class action

Can You File a Hernia Mesh Lawsuit Right Now?

Yes, if your case involves a manufacturer whose litigation hasn’t already settled — but there’s no single form that covers every mesh patient.

C.R. Bard’s parent, Becton Dickinson, already resolved the large majority of its claims in October 2024, so a new Bard case now enters an active settlement-administration process rather than a fresh lawsuit. Covidien litigation, by contrast, is still fully open: only about 2,449 of an estimated 10,350+ Covidien claims nationwide have reached MDL No. 3029, and the August 2026 verdict suggests the company may face pressure to negotiate. Atrium C-Qur claims are mostly resolved, with 139 still active out of 3,592 historically filed. Ethicon’s Physiomesh litigation has largely wound down through confidential settlements.

Whether you can act depends on your implant manufacturer, implantation date, symptoms, and your state’s filing deadline — which can run from the date of injury or from when you reasonably discovered its possible link to the mesh. Anyone who hasn’t filed should pull their implant records and talk to a product-liability attorney promptly rather than wait for a hypothetical nationwide settlement fund.

What the Hernia Mesh Lawsuit Alleges

Hernia mesh is implanted to reinforce weakened abdominal tissue after a hernia repair. None of the pending litigation claims that every mesh product or every hernia operation is defective — the suits target specific products and design choices.

Depending on the manufacturer, allegations involve polypropylene mesh degradation, absorbable coatings that dissolved faster than represented, mesh shrinkage, migration, adhesion to internal organs, inadequate warning labels, and mesh that was difficult to surgically remove. The FDA lists pain, infection, recurrent hernia, adhesions, bowel obstruction, bleeding, fistula, fluid buildup, and perforation as complications reported after hernia repair — complications that can also occur without a defective device, so a bad outcome alone doesn’t prove a legal claim.

Bard Hernia Mesh Settlement: Where the $1 Billion-Plus Deal Stands

MDL No. 2846, based in the Southern District of Ohio, is the largest of the four federal mesh proceedings. In October 2024, Becton Dickinson — which owns Bard and Davol — agreed to resolve more than 38,000 federal and Rhode Island state-court claims for a settlement Bloomberg and Reuters both reported exceeds $1 billion. That figure represented the “vast majority” of the $1.7 billion Becton Dickinson had reserved for product-liability matters; the company admitted no wrongdoing.

A Qualified Settlement Fund, managed through Wells Fargo, was established in early 2025, and special masters now oversee distribution. Claimants who settled before June 5, 2025, had 10% withheld for legal fees; payments processed after that date go directly into the fund. Individual payout amounts are confidential, and multiple sources describe a tiered, points-based structure where documentation quality — not just injury severity — determines whether a claimant lands near the low or high end of the range. As of August 3, 2026, the Judicial Panel on Multidistrict Litigation still listed 23,321 pending actions in the MDL, but a case remaining on the docket doesn’t mean it’s contested; many are simply working through release, payment, or dismissal paperwork.

Covidien Hernia Mesh Lawsuit and the $88 Million Verdict

Covidien, a Medtronic subsidiary, is the manufacturer facing the most active hernia mesh litigation right now. Its federal cases are coordinated in MDL No. 3029 before Judge Patti B. Saris in Boston, covering the Parietex, ProGrip, and Symbotex product lines.

On August 4, 2026, a federal jury in Patterson v. Covidien awarded Larry Patterson $77 million and his wife, Tammy, $11 million for loss of consortium — $88 million total. The jury found Covidien failed to adequately warn doctors that Symbotex’s collagen barrier coating could dissolve within about a week rather than the month the company allegedly represented; that gap, jurors found, contributed to Patterson’s 2020 bowel obstruction after his 2017 implant surgery. The jury did not find fraud and awarded no punitive damages. Medtronic has said it will challenge the award through post-trial motions and a likely appeal, and it maintains the mesh performed as designed.

This was the first of more than 2,400 federal Covidien lawsuits to reach a jury, alongside roughly 7,450 additional cases pending in Massachusetts state court. A single bellwether verdict doesn’t set a payout standard for other claimants — each plaintiff still has to independently prove product identification, causation, and damages — but it does give attorneys on both sides a data point for future settlement talks.

Atrium C-Qur and Ethicon Physiomesh: Mostly Resolved, Not Fully Closed

Atrium’s C-Qur mesh cases are centralized in MDL No. 2753 in the District of New Hampshire. Federal courts reported 139 pending actions against 3,592 historically filed as of August 3, 2026 — a sharp drop that reflects a settlement fund Atrium set aside starting around $66 million, though most individual terms remain undisclosed.

Ethicon’s Physiomesh Flexible Composite Mesh litigation, once centralized as MDL No. 2782 in the Northern District of Georgia, has largely wound down through confidential settlements and no longer appears among the JPML’s actively transferred proceedings. That doesn’t mean every possible claim has closed — Physiomesh Open, a separate product, was never part of that MDL, and state-court or newly discovered cases can still surface.

Hernia Mesh Lawsuit Timeline

  • December 2016 — Atrium C-Qur cases centralized as MDL No. 2753.
  • June 2017 — Ethicon Physiomesh cases centralized as MDL No. 2782.
  • August 2018 — Bard polypropylene mesh cases centralized as MDL No. 2846.
  • January 2024 — Covidien cases centralized as MDL No. 3029, starting with 900 cases and growing past 2,500.
  • October 2024 — Becton Dickinson announces the ~38,000-claim Bard settlement.
  • Early 2025 — Bard’s Qualified Settlement Fund and intensive settlement process go live.
  • August 4, 2026 — Jury returns the $88 million Patterson v. Covidien verdict.

Evidence You Need to File a Hernia Mesh Lawsuit

A workable claim generally needs documentation identifying the exact product implanted, not just a general hernia-surgery history:

  • The operative report from the original hernia repair
  • Implant stickers or device-identification records
  • Hospital and surgeon records
  • Imaging reports
  • Records of infections, obstructions, or recurrent hernias
  • Revision or mesh-removal surgery reports
  • Employment or expense records supporting financial-loss claims

Don’t undergo mesh-removal surgery solely to build a case file — treatment decisions should be made with a physician based on medical need, not litigation strategy.

Hernia Mesh Lawsuit Settlement Payouts: What’s Actually Confirmed

There is no verified, universal payout figure for hernia mesh claims, and any chart promising a fixed dollar amount by symptom alone should be treated skeptically. Bard’s overall settlement value and individual allocations remain confidential, as do most Ethicon payments. Atrium’s fund started around $66 million with undisclosed individual terms. The $88 million Covidien verdict is real and detailed — $77 million compensatory to Larry Patterson, $11 million to his wife — but it covers one couple’s evidence, remains subject to post-trial motions, and isn’t a template for other Covidien claimants’ eventual settlements.

Litigation over hernia mesh is still moving in 2026, but no universal claims form exists and no guaranteed payout applies across manufacturers. Anyone weighing a hernia mesh lawsuit should confirm their implant’s manufacturer, gather medical records, and get a deadline assessment from a qualified attorney before assuming which category — settled, settling, or still contested — their case falls into.

Frequently Asked Questions

Is the hernia mesh lawsuit a class action?

No. Nearly all claims are individual product-liability lawsuits coordinated for pretrial purposes through multidistrict litigation. An MDL streamlines discovery and motions, but each plaintiff’s case is still evaluated on its own facts.

Is the Bard hernia mesh settlement final?

Bard’s parent, Becton Dickinson, reached an agreement covering roughly 38,000 claims in October 2024, and a Qualified Settlement Fund began distributing payments in 2025. Individual payout terms remain confidential, and thousands of cases were still processing through the fund as of August 2026.

Can I submit a Bard settlement claim online?

No general public claims form exists. Participation runs through attorneys already representing eligible claimants in the coordinated litigation.

Does the $88 million Covidien verdict set the payout for other claims?

No. It’s a bellwether verdict based on one plaintiff couple’s evidence, and Medtronic has said it will appeal. It doesn’t establish an automatic value for the other 2,400-plus pending federal Covidien cases.

What injuries are commonly alleged?

Chronic pain, infection, adhesions, bowel obstruction, mesh migration, recurrent hernia, perforation, and the need for revision surgery. A complication alone doesn’t prove a product defect — causation still has to be shown.

How long do I have to file a hernia mesh lawsuit?

It depends on your state’s statute of limitations, which can start at the date of injury or when you reasonably discovered a possible link to the mesh. An attorney needs to evaluate your specific facts and jurisdiction.

Has every hernia mesh product been recalled?

No. Ongoing litigation or an adverse-event report doesn’t mean a given hernia mesh product has been recalled or judicially found defective.

Sources

  • U.S. Judicial Panel on Multidistrict Litigation — MDL statistics report, August 2026: https://www.jpml.uscourts.gov/pending-mdls-0
  • Reuters/Insurance Journal — “Becton Dickinson Hernia-Mesh Settlements Will Exceed $1 Billion” (Oct. 4, 2024): https://www.insurancejournal.com/news/national/2024/10/04/795805.htm
  • FindLaw Courtside — “Bellwether Trial Verdict Goes Against Medtronic in Covidien Hernia Mesh Lawsuit”: https://www.findlaw.com/legalblogs/courtside/bellwether-trial-verdict-goes-against-medtronic-in-covidien-hernia-mesh-lawsuit/
  • Top Class Actions — “Covidien hit with $88M verdict in first bellwether hernia mesh trial”: https://topclassactions.com/lawsuit-settlements/lawsuit-news/covidien-hit-with-88m-verdict-in-first-bellwether-hernia-mesh-trial/
  • U.S. Food and Drug Administration — hernia surgical mesh complications reporting

Leave a Reply

Your email address will not be published. Required fields are marked *